Case series demonstrating improvement in chronic cutaneous sarcoidosis following treatment with TNF inhibitors

Archives of Dermatology

Volumn 148, Issue 9, 2012, Pages 1097-1100

  Wanat, Karolyn A ^a   Rosenbach, Misha ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CHLOROQUINE; DOXYCYCLINE; HYDROXYCHLOROQUINE; INFLIXIMAB; MEPACRINE; METHOTREXATE; MINOCYCLINE; MYCOPHENOLIC ACID; PREDNISONE; STEROID; THALIDOMIDE; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG DOSE INCREASE; FEMALE; HEALTH INSURANCE; HUMAN; MALE; MINIMAL RESIDUAL DISEASE; PATIENT PREFERENCE; PRIORITY JOURNAL; RECURRENT DISEASE; SARCOIDOSIS; SKIN DEFECT; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT RESPONSE;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; SARCOIDOSIS; SKIN DISEASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84866495871     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2012.1322     Document Type: Article

References (5)

1. Judson MA. Successful treatment of lupus pernio with adalimumab. Arch Dermatol. 2011;147(11):1332-1333.
2. Stagaki E, Mountford WK, Lackland DT, Judson MA. The treatment of lupus pernio: results of 116 treatment courses in 54 patients. Chest. 2009;135(2):468-476.
3. Heffernan MP, Smith DI. Adalimumab for treatment of cutaneous sarcoidosis. Arch Dermatol. 2006;142(1):17-19.
4. Burns AM, Green PJ, Pasternak S. Etanercept-induced cutaneous and pulmonary sarcoid-like granulomas resolving with adalimumab. J Cutan Pathol. 2012;39(2):289-293.
5. Utz JP, Limper AH, Kalra S, et al. Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest. 2003;124(1):177-185.